Business Description
Ironwood Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US46333X1081
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | -0.75 | |||||
Debt-to-Equity | -2.09 | |||||
Debt-to-EBITDA | -0.71 | |||||
Interest Coverage | 4.4 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -11.21 | |||||
Beneish M-Score | -4.55 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.5 | |||||
3-Year FCF Growth Rate | 4.3 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.32 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 51.53 | |||||
9-Day RSI | 46.83 | |||||
14-Day RSI | 42.52 | |||||
6-1 Month Momentum % | -21.16 | |||||
12-1 Month Momentum % | -30.37 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.82 | |||||
Quick Ratio | 0.82 | |||||
Cash Ratio | 0.48 | |||||
Days Sales Outstanding | 98.93 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.9 | |||||
Shareholder Yield % | -32.16 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 28.94 | |||||
Net Margin % | -254.41 | |||||
FCF Margin % | 35.73 | |||||
ROA % | -164.78 | |||||
ROIC % | 26.97 | |||||
ROC (Joel Greenblatt) % | -1204.22 | |||||
ROCE % | -238.97 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.51 | |||||
Price-to-Free-Cash-Flow | 6.97 | |||||
Price-to-Operating-Cash-Flow | 6.95 | |||||
EV-to-EBIT | -1.61 | |||||
EV-to-EBITDA | -1.61 | |||||
EV-to-Revenue | 3.82 | |||||
EV-to-FCF | 10.67 | |||||
Price-to-Projected-FCF | 1.1 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Earnings Yield (Greenblatt) % | -62.11 | |||||
FCF Yield % | 14.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ironwood Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 382.37 | ||
EPS (TTM) (€) | -6.266 | ||
Beta | 0.29 | ||
Volatility % | 62.5 | ||
14-Day RSI | 42.52 | ||
14-Day ATR (€) | 0.209651 | ||
20-Day SMA (€) | 5.805 | ||
12-1 Month Momentum % | -30.37 | ||
52-Week Range (€) | 5.3 - 14.5 | ||
Shares Outstanding (Mil) | 158.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ironwood Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ironwood Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Ironwood Pharmaceuticals Inc Frequently Asked Questions
What is Ironwood Pharmaceuticals Inc(STU:I76)'s stock price today?
When is next earnings date of Ironwood Pharmaceuticals Inc(STU:I76)?
Does Ironwood Pharmaceuticals Inc(STU:I76) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |